Use of leucyl tRNA synthetase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9435807
APP PUB NO 20140249045A1
SERIAL NO

14223188

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a method of screening for agents for preventing or treating mTORC 1 mediated diseases by screening test agents to determine test agents that inhibit the binding ability of LRS to RagD, or RagD GTPases, and a method of reducing cell size as compared to the control group, including inhibiting the expression of intracellular LRS in the cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDICINAL BIOCONVERGENCE RESEARCH CENTERSEOUL 151-1742 CROWN YUE QU SHI LIDONG HILL 56-1 SEOUL UNIVERSITY 105-1 HOLE 307 FLOOR

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Han, Jung Min Seoul, KR 27 144
Kim, Sunghoon Seoul, KR 400 3449

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00